VACCINES UNDER TRIAL
Dec 02, 2020
2 minutes
BNT162b2 (Pfizer and BioNTech)
his vaccine was one of two versions put through the paces. It emerged triumphant as it was found to produce a lower number of severe side-effects. The vaccine itself is administered over two separate doses, several weeks apart. Since the launch of Phase II/III trials in July, it has been tested
You’re reading a preview, subscribe to read more.
Start your free 30 days